Literature DB >> 8571340

APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population.

O Takamiya, F Ishida, H Kodaira, K Kitano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8571340

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  13 in total

Review 1.  Recent advances in haematology.

Authors:  D Provan; D F O'Shaughnessy
Journal:  BMJ       Date:  1999-04-10

2.  Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype.

Authors:  Hiromi Okada; Yoshimi Toyoda; Akira Takagi; Hidehiko Saito; Tetsuhito Kojima; Tomio Yamazaki
Journal:  Int J Hematol       Date:  2010-03-20       Impact factor: 2.490

Review 3.  Genetics and pulmonary medicine. 4. Pulmonary embolism.

Authors:  M Laffan
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

4.  Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.

Authors:  N Irani-Hakime; H Tamim; G Elias; S Choueiry; R Kreidy; J L Daccache; W Y Almawi
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

5.  Frequent association of thrombophilia in cerebral venous sinus thrombosis.

Authors:  Makoto Ikejiri; Akihiro Shindo; Yuichiro Ii; Hidekazu Tomimoto; Norikazu Yamada; Takeshi Matsumoto; Yasunori Abe; Kaname Nakatani; Tsutomu Nobori; Hideo Wada
Journal:  Int J Hematol       Date:  2012-03       Impact factor: 2.490

6.  Polymorphisms in Factor II and Factor V thrombophilia genes among Circassians in Jordan.

Authors:  R Dajani; A Arafat; N Hakooz; Z Al-Abbadi; Al-Motassem Yousef; M El Khateeb; F Quadan
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

7.  Prevalence of factor V Leiden in a Canadian blood donor population.

Authors:  D H Lee; P A Henderson; M A Blajchman
Journal:  CMAJ       Date:  1996-08-01       Impact factor: 8.262

8.  A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation.

Authors:  Nobuo Aoki; Tamotsu Matsuda; Hidehiko Saito; Kiyoshi Takatsuki; Kenji Okajima; Hoyu Takahashi; Junki Takamatsu; Hidesaku Asakura; Nobuya Ogawa
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

9.  Risk factors of venous thromboembolism in thai patients.

Authors:  Pantep Angchaisuksiri; Vichai Atichartakarn; Katcharin Aryurachai; Napaporn Archararit; Buppa Rachakom; Kanlayanee Atamasirikul; Arjit Tiraganjana
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

10.  Clinical features and underlying causes of cerebral venous thrombosis in Japanese patients.

Authors:  Akihiro Shindo; Hideo Wada; Hidehiro Ishikawa; Ai Ito; Masaru Asahi; Yuichiro Ii; Makoto Ikejiri; Hidekazu Tomimoto
Journal:  Int J Hematol       Date:  2014-03-06       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.